PMID- 18534980 OWN - NLM STAT- MEDLINE DCOM- 20080908 LR - 20240512 IS - 0021-9258 (Print) IS - 1083-351X (Electronic) IS - 0021-9258 (Linking) VI - 283 IP - 30 DP - 2008 Jul 25 TI - Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. PG - 21134-44 LID - 10.1074/jbc.M801954200 [doi] AB - Mitochondrial oxidative phosphorylation provides most cellular energy. As part of this process, cytochrome c oxidase (CcO) pumps protons across the inner mitochondrial membrane, contributing to the generation of the mitochondrial membrane potential, which is used by ATP synthase to produce ATP. During acute inflammation, as in sepsis, aerobic metabolism appears to malfunction and switches to glycolytic energy production. The pro-inflammatory cytokine tumor necrosis factor alpha (TNFalpha) has been shown to play a central role in inflammation. We hypothesized that TNFalpha-triggered cell signaling targets CcO, which is a central enzyme of the aerobic energy metabolism and can be regulated through phosphorylation. Using total bovine and murine hepatocyte homogenates TNFalpha treatment led to an approximately 60% reduction in CcO activity. In contrast, there was no direct effect of TNFalpha on CcO activity using isolated mitochondria and purified CcO, indicating that a TNFalpha-triggered intracellular signaling cascade mediates CcO inhibition. CcO isolated after TNFalpha treatment showed tyrosine phosphorylation on CcO catalytic subunit I and was approximately 50 and 70% inhibited at high cytochrome c concentrations in the presence of allosteric activator ADP and inhibitor ATP, respectively. CcO phosphorylation occurs on tyrosine 304 as demonstrated with a phosphoepitope-specific antibody. Furthermore, the mitochondrial membrane potential was decreased in H2.35 cells in response to TNFalpha. Concomitantly, cellular ATP was more than 35 and 64% reduced in murine hepatocytes and H2.35 cells. We postulate that an important contributor in TNFalpha-mediated pathologies, such as sepsis, is energy paucity, which parallels the poor tissue oxygen extraction and utilization found in such patients. FAU - Samavati, Lobelia AU - Samavati L AD - Department of Medicine, Division of Pulmonary/Critical Care and Sleep Medicine, Wayne State University School of Medicine, 3990 John R., Detroit, MI 48201, USA. lsamavat@med.wayne.edu FAU - Lee, Icksoo AU - Lee I FAU - Mathes, Isabella AU - Mathes I FAU - Lottspeich, Friedrich AU - Lottspeich F FAU - Huttemann, Maik AU - Huttemann M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080605 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Tumor Necrosis Factor-alpha) RN - 42HK56048U (Tyrosine) RN - EC 1.9.3.1 (Electron Transport Complex IV) RN - EC 2.7.4.- (ATP Synthetase Complexes) SB - IM MH - ATP Synthetase Complexes/metabolism MH - Animals MH - Cattle MH - Cells, Cultured MH - Electron Transport Complex IV/*metabolism MH - Glycolysis MH - Mice MH - Mice, Inbred C57BL MH - Mitochondria/metabolism MH - Models, Biological MH - *Oxidative Phosphorylation MH - Phosphorylation MH - Signal Transduction MH - Tumor Necrosis Factor-alpha/*metabolism MH - Tyrosine/*chemistry PMC - PMC3258931 EDAT- 2008/06/07 09:00 MHDA- 2008/09/09 09:00 PMCR- 2009/07/25 CRDT- 2008/06/07 09:00 PHST- 2008/06/07 09:00 [pubmed] PHST- 2008/09/09 09:00 [medline] PHST- 2008/06/07 09:00 [entrez] PHST- 2009/07/25 00:00 [pmc-release] AID - S0021-9258(19)54736-6 [pii] AID - 21134 [pii] AID - 10.1074/jbc.M801954200 [doi] PST - ppublish SO - J Biol Chem. 2008 Jul 25;283(30):21134-44. doi: 10.1074/jbc.M801954200. Epub 2008 Jun 5.